Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Martina Curto, Francesco Fazio, Martina Ulivieri, Serena Navari, Luana Lionetto & Ross J Baldessarini. (2021) Improving adherence to pharmacological treatment for schizophrenia: a systematic assessment. Expert Opinion on Pharmacotherapy 22:9, pages 1143-1155.
Read now
Read now
Michael J Doane, Martha Sajatovic, Peter J Weiden, Amy K O’Sullivan, Stephen Maher, Jakob B Bjorner, Asia Sikora Kessler, Julia Carpenter-Conlin, Leona Bessonova & Dawn I Velligan. (2020) Antipsychotic Treatment Experiences of People with Schizophrenia: Patient Perspectives from an Online Survey. Patient Preference and Adherence 14, pages 2043-2054.
Read now
Read now
Articles from other publishers (11)
Nagesh Pai, Andrew B McGeachie, Andrea Puig, Tom H-W Huang & Prachi Brahmbhatt. (2022) Persistence and adherence to second-generation antipsychotic long-acting injectable medications for schizophrenia: A comparative study in the Australian context. Australasian Psychiatry 31:1, pages 76-81.
Crossref
Crossref
Gabriel G. Edwards, Ayako Miyashita-Ochoa, Enrico G. Castillo, David Goodman-Meza, Ippolytos Kalofonos, Raphael J. Landovitz, Arleen A. Leibowitz, Craig Pulsipher, Ed El Sayed, Steven Shoptaw, Chelsea L. Shover, Michelle Tabajonda, Yvonne S. Yang & Nina T. Harawa. (2022) Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine. AIDS and Behavior 27:1, pages 10-24.
Crossref
Crossref
Stefano Barlati, Gabriele Nibbio, Francesco Bianchi, Elena Butti Lemmi Gigli, Irene Calzavara-Pinton, Caterina Cerati, Jacopo Fiori, Jacopo Lisoni, Giacomo Deste & Antonio Vita. (2022) Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting. Psychiatry Research 317, pages 114878.
Crossref
Crossref
Chizimuzo T.C. Okoli, Amani Kappi, Tianyi Wang, Andrew Makowski & Andrew T. Cooley. (2021) The effect of long‐acting injectable antipsychotic medications compared with oral antipsychotic medications among people with schizophrenia: A systematic review and meta‐analysis. International Journal of Mental Health Nursing 31:3, pages 469-535.
Crossref
Crossref
Donica Janzen, James M. Bolton, Christine Leong, I fan Kuo & Silvia Alessi-Severini. (2022) Second-Generation Long-Acting Injectable Antipsychotics and the Risk of Treatment Failure in a Population-Based Cohort. Frontiers in Pharmacology 13.
Crossref
Crossref
Kyle A. McKee, Candice E. Crocker & Philip G. Tibbo. (2021) Long-acting injectable antipsychotic (LAI) prescribing trends during COVID-19 restrictions in Canada: a retrospective observational study. BMC Psychiatry 21:1.
Crossref
Crossref
Sun Lee & Shaina Schwartz. (2021) Adherence and persistence to long-acting injectable dopamine receptor blocking agent therapy in the United States: A systematic review and meta-analysis of cohort studies. Psychiatry Research 306, pages 114277.
Crossref
Crossref
Rebekka Lencer, Maria Paz Garcia-Portilla, Paul Bergmans, Srihari Gopal, Maju Mathews, Annette Wooller & Katalin Pungor. (2021) Impact on carer burden when stable patients with schizophrenia transitioned from 1-monthly to 3-monthly paliperidone palmitate. Comprehensive Psychiatry 107, pages 152233.
Crossref
Crossref
Taishiro Kishimoto, Katsuhiko Hagi, Shunya Kurokawa, John M Kane & Christoph U Correll. (2021) Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies. The Lancet Psychiatry 8:5, pages 387-404.
Crossref
Crossref
Xiaobing Guo, Hongye Yu & Hu Wang. (2021) Antipsychotic patterns in outpatients with schizophrenia in China. Medicine 100:32, pages e26912.
Crossref
Crossref
Nakao Iwata, Ataru Inagaki, Hiromi Sano, Kazunari Niidome, Yoshitsugu Kojima & Sakiko Yamada. (2020) Treatment Persistence Between Long-Acting Injectable Versus Orally Administered Aripiprazole Among Patients with Schizophrenia in a Real-World Clinical Setting in Japan. Advances in Therapy 37:7, pages 3324-3336.
Crossref
Crossref